one-way anova followed by newman-keuls post hoc test for multiple comparisons (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
one-way anova followed by newman-keuls post hoc test for multiple comparisons
One Way Anova Followed By Newman Keuls Post Hoc Test For Multiple Comparisons, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/one-way+anova+followed+by+newman%E2%80%93keuls+post+hoc+multiple+comparisons+test/one+way+anova+with+newman+keuls+comparison+program/pm28567512-87-14-25
Average 90 stars, based on 1 article reviews
One Way Anova Followed By Newman Keuls Post Hoc Test For Multiple Comparisons, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/one-way+anova+followed+by+newman%E2%80%93keuls+post+hoc+multiple+comparisons+test/one+way+anova+with+newman+keuls+comparison+program/pm28567512-87-14-25
Average 90 stars, based on 1 article reviews
one-way anova followed by newman-keuls post hoc test for multiple comparisons - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Selective in vivo antagonism of endothelin receptors in transforming growth factor-β1 transgenic mice that mimic the vascular pathology of Alzheimer’s diseaseThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research. Article Snippet: Increased levels of transforming growth factor-b1 (TGF-b1) induce a vascular pathology that shares similarities with that seen in Alzheimer’s disease, and which possibly contributes to the cognitive decline.. In aged transgenic mice that overexpress TGF-b1 (TGF mice), we previously found reduced dilatory function and selectively impaired endothelin-1 (ET-1)-induced contraction.. Here we studied the effects of chronic treatments with selective ETA (ABT-627) or ETB (A-192621) receptor antagonist on cerebrovascular reactivity, cerebral perfusion, or memory performance. |